REITs may offer diversification and sustainability benefits, particularly during periods of moderate to high inflation.
As measured by research output and FDA drug approvals, innovation has reached
all-time highs in recent years.
Overburdened supply chains and persistent inflation threaten economic and profit growth.
Stocks have historically shielded investors from inflation’s fury. Choosing the stocks of companies with strong pricing power may make an even greater difference.
Our Non-U.S. Growth portfolio team weighs in on how the Russia-Ukraine conflict may affect energy security, inflation and earnings.
After an extended period of strong returns, growth-oriented stock investors have experienced a more volatile environment in recent months.
A select group of American Century Investments’ thought leaders share perspectives on the global economy and opportunities they see for fixed income, value equities and multi-asset strategies.
The U.S. Securities and Exchange Commission (SEC) recently finalized amendments that implement disclosure and submission requirements of the Holding Foreign Companies Accountable (HFCA) Act.
Many companies reporting strong results have held up better than their weaker counterparts.
Health care companies are adapting to a world shaped by the impacts
In this Q&A, Senior Portfolio Manager Rajesh Gandhi discusses the current market environment for non-U.S. equities, noting certain secular trends we believe will continue to support earnings growth.
In this Q&A, Senior Investment Director Chris Chen moderates a discussion
between Senior Portfolio Managers Mike Liss and Brent Puff about the often-debated potential advantages of growth- and value-oriented investment styles.
Get our investment team’s take about how this high-conviction, large-cap growth strategy performed during the past quarter.
New regulations aimed at education and technology companies have led to market uncertainty and volatility in China.
China’s long-term growth plans are based on establishing a consumer-based economic system centered around technology and innovation.
Hear directly from our global growth investment team on performance, portfolio positioning and the market environment.
Hear directly from our emerging markets equity investment team on performance, portfolio positioning and the market environment.
Hear directly from our global small cap investment team on performance, portfolio positioning and the market environment.
We see opportunities in smaller-cap biopharma companies developing treatments and cures for unmet medical needs.
Is earnings acceleration an underused source of diversification and excess return? See what the new data shows across regions, sectors and factors in different market environments.
Senior Portfolio Manager Michael Li discusses Biogen, a company with the potential of doing well financially over the long term and focusing on social good with its breakthrough treatment.
See how we have integrated ESG analysis alongside traditional financial evaluation to identify sustainable companies that offer the potential to deliver excess returns over time.
We believe the market’s focus on short-term results creates opportunities for long-term investors in ground-breaking companies like Tesla.
Get to know Portfolio Manager Prabha Ram, a key member of the American Century U.S. Focused Dynamic Growth strategy investment team.
When it comes to finding compelling investment opportunities outside the U.S., style may not matter as much as you think.
The low-volatility anomaly is an investment phenomenon that challenges
conventional stock market theories.
We believe the travel industry might be poised to rebound significantly.
The 2021 outlook for global small caps from Sr. Client Portfolio Manager, Jim Shore.
Investors might consider positioning their portfolios in an effort to take
advantage of these potential opportunities.
Exposure to small-cap equities could benefit investors in 2021 and beyond.
Can my investments do well while the companies I invest in do good? This is a question many investors ask as they consider portfolios that assess ESG factors as part of the investment process.
We believe active outperformance results from making investment decisions within
the context of a company’s stage of development—rather than in isolation over a
short horizon—and supported by differentiated, rigorous fundamental research.
Biden has pledged to work with Republicans on Capitol Hill. Failing that, he won’t be powerless to pursue his agenda.
As many predicted, we find ourselves in an unsettled situation as election officials nationwide count votes in the contentious U.S. presidential election.
Each generation of wireless technology enabled faster speeds and innovation. Could 5G also pave the way for improved social and environmental issues?
The Affordable Care Act (ACA) is one example that demonstrates the pitfalls of investing based on political outcomes.
We see opportunities in under-the-radar companies like laser manufacturers, but you can’t take a passive approach to finding them.
Find out why we view Tesla as a transformative technology company positioned for growth well into the future.
New investment opportunities in emerging markets (EM) are resulting from the coronavirus pandemic’s impact on consumer behavior.
Focusing on quality has historically led us to companies with strong financial and ESG characteristics.
There's a lot of talk about ESG investing. However, few managers have focused on emerging markets—and that's where we see a lot of potential.
Trade war aside, Sr. Portfolio Manager Patricia Ribeiro is still finding opportunities to invest in China. Find out how in her latest quarterly update.
Senior Portfolio Manager Trevor Gurwich explains why the larger opportunity set and domestic focus of global small-cap equities make them well positioned to weather market pressures in the current environment.
Learn why we believe high-quality, dividend-paying U.S. companies may offer solid risk/reward potential.